CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

UNKNOWN

Identifier: CI-TRIAL-00030361
Entity page: /trial/NCT01746992 ↗
Edges: 12

Neighbours: 5 cancers7 drugs
Drawn: 12 of 12 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma condition of …CONDITION_OFderived5 of 5
← condition of	Anaplastic Large Cell Lymphoma, ALK-Negative registry condition “ALK-negative Anaplastic Large Cell Lymphoma” mapped ALIAS	—	—	Anaplastic Large Cell Lymphoma, ALK-Negative	1	Observed	clinicaltrials	graph →
← condition of	Enteropathy-Associated T-Cell Lymphoma

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma intervention of …INTERVENTION_OFderived7 of 7
← intervention of	Cyclophosphamidesmall molecule registry intervention “Cyclophosphamide 750mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Doxorubicinsmall molecule registry intervention “Doxorubicin 50mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Etoposidesmall molecule registry intervention “Etoposide phosphate 100mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Ifosfamidesmall molecule registry intervention “ifosfamide 2000mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Methotrexatesmall molecule registry intervention “methotrexate 1500mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Prednisonesmall molecule registry intervention “prednisone 60mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Vincristinesmall molecule registry intervention “Vincristine 1.4mg/m2” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma intervention of …INTERVENTION_OFderived7 of 7

← intervention of

Cyclophosphamidesmall molecule

registry intervention “Cyclophosphamide 750mg/m2” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Doxorubicinsmall molecule

registry intervention “Doxorubicin 50mg/m2” (DRUG) mapped ALIAS

—